Virobay
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section needs expansion. You can help by adding to it. (July 2020) |
| Industry | Pharmaceutical companies |
|---|---|
| Founded | 1 January 2006  |
| Headquarters | , United States |
| Website | www |
| Footnotes / references location[1] | |
Virobay is an American pharmaceutical company which develops drugs using a proprietary cysteine cathepsin platform.[1]
References[edit]
- ^ a b House, Douglas W. (7 Oct 2014). "Virobay on deck for IPO". Seeking Alpha.
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |